Fatality risks for nosocomial outbreaks of Middle East respiratory syndrome coronavirus in the Middle East and South Korea.
Fatality risks for nosocomial outbreaks of Middle East respiratory syndrome coronavirus in the Middle East and South Korea.
复制标题
DOI:
10.1007/s00705-016-3062-x
复制
发表时间:
2017-01
影响因子:
2.7
通讯作者:
Liu S
中科院分区:
文献类型:
--
作者:
Sha J;Li Y;Chen X;Hu Y;Ren Y;Geng X;Zhang Z;Liu S
Middle East respiratory syndrome coronavirus (MERS-CoV) was first isolated in 2012. The largest known outbreak outside the Middle East occurred in South Korea in 2015. As of 29 June 2016, 1769 laboratory-confirmed cases (630 deaths; 35.6 % case fatality rate [CFR]) had been reported from 26 countries, particularly in the Middle East. However, the CFR for hospital outbreaks was higher than that of family clusters in the Middle East and Korea. Here, we compared the mortality rates for 51 nosocomial outbreaks in the Middle East and one outbreak of MERS-CoV in South Korea. Our findings showed the CFR in the Middle East was much higher than that in South Korea (25.9 % [56/216] vs. 13.8 % [24/174], p = 0.003). Infected individuals who died were, on average, older than those who survived in both the Middle East (64 years [25–98] vs. 46 years [2–85], p = 0.000) and South Korea (68 years [49–82] vs. 53.5 years [16–87], p = 0.000). Similarly, the co-morbidity rates for the fatal cases were statistically higher than for the nonfatal cases in both the Middle East (64.3 % [36/56] vs. 28.1 % [45/160], p = 0.000) and South Korea (45.8 % [11/24] vs. 12.0 % [18/150], p = 0.000). The median number of days from onset to confirmation of infection in the fatal cases was longer than that for survivors from the Middle East (8 days [1–47] vs. 4 days [0–14], p = 0.009). Thus, older age, pre-existing concurrent diseases, and delayed confirmation increase the odds of a fatal outcome in nosocomial MERS-CoV outbreaks in the Middle East and South Korea. The online version of this article (doi:10.1007/s00705-016-3062-x) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
1.6
作者:
Khalid M;Khan B;Al Rabiah F;Alismaili R;Saleemi S;Rehan-Khaliq AM;Weheba I;Al Abdely H;Halim M;Nadri QJ;Al Dalaan AM;Zeitouni M;Butt T;Al Mutairy E
通讯作者:
Al Mutairy E
DOI:
10.1093/cid/ciu812
发表时间:
2015-02-01
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Drosten C;Muth D;Corman VM;Hussain R;Al Masri M;HajOmar W;Landt O;Assiri A;Eckerle I;Al Shangiti A;Al-Tawfiq JA;Albarrak A;Zumla A;Rambaut A;Memish ZA
通讯作者:
Memish ZA
影响因子:
3.7
作者:
Liu S;Chan TC;Chu YT;Wu JT;Geng X;Zhao N;Cheng W;Chen E;King CC
通讯作者:
King CC
影响因子:
11.8
作者:
Assiri A;Abedi GR;Bin Saeed AA;Abdalla MA;al-Masry M;Choudhry AJ;Lu X;Erdman DD;Tatti K;Binder AM;Rudd J;Tokars J;Miao C;Alarbash H;Nooh R;Pallansch M;Gerber SI;Watson JT
通讯作者:
Watson JT
影响因子:
3.8
作者:
Chowell G;Blumberg S;Simonsen L;Miller MA;Viboud C
通讯作者:
Viboud C